A systematic review of optical coherence tomography findings in adults with mild traumatic brain injury
Hannah S. Lyons,Matilde Sassani,Yousef Hyder,James L. Mitchell,Mark Thaller,Susan P. Mollan,Alexandra J. Sinclair,Alexandra Sinclair,Aliza Finch,Adam Hampshire,Alice Sitch,Ali Mazaheri,Andrew Bagshaw,Andy Palmer,Asha Strom,Alice Waitt,Andreas Yiangou,Ahmed Abdel-Hay,Alexander Bennett,Amy Clark,Angus Hunter,Barry Seemungal,Caroline Witton,Caroline Dooley,Deborah Bird,Davinia Fernandez-Espejo,Dave Smith,Dan Ford,Daniel Sherwood,Donna Holding,Duncan Wilson,Edward Palmer,John Golding,Hamid Dehghani,Hyojin Park,Hannah Lyons,Hazel Smith,Helen Brunger,Henrietta Ellis,Iman Idrees,Ian Varley,Jessica Hubbard,Jun Cao,Jon Deeks,James Mitchell,Jan Novak,Jamie Pringle,John Terry,Jack Rogers,Tim Read,Jessikah Fildes,Karen Mullinger,Lisa Hill,Marco Aurisicchio,Mark Thaller,Martin Wilson,Mark Pearce,Matilde Sassani,Matthew Brookes,Mohammad Mahmud,Ray Rayhan,Ned Jenkinson,Niki Karavitaki,Nick Capewell,Olivia Grech,Ole Jensen,Pete Hellyer,Philip Woodgate,Sebastian Coleman,Raymond Reynolds,Richard J. Blanch,Katie Morris,Ryan Ottridge,Rachel Upthegrove,Ronan Dardis,Ruwan Wanni Arachchige,Sarah Berhane,Sam Lucas,Sophie Prosser,Shayan Sharifi,Shreshth Dharm-Datta,Susan Mollan,Toby Ellmers,Tara Ghafari,Tony Goldstone,Waheeda Hawa,Yidian Gao,Richard J. Blanch
DOI: https://doi.org/10.1038/s41433-023-02845-w
IF: 4.4563
2024-01-19
Eye
Abstract:Mild traumatic brain injury (mTBI) is common with many patients suffering disabling long-term sequelae, with visual symptoms frequently reported. There are no objective biomarkers of mTBI that are routinely used in clinical practice. Optical coherence tomography (OCT) has been used in mTBI research, as it enables visualisation of the neuroretina, allowing measurement of the retinal nerve fibre layer and ganglion cell layer. This systematic review aims to appraise the available literature and assess whether there are significant changes within the retinal nerve fibre layer and ganglion cell layer in subjects after mTBI. A systematic review was carried out in accordance with PRISMA guidelines and registered with PROSPERO (Number: CRD42022360498). Four databases were searched for relevant literature published from inception until 1 September 2022. s and full texts were screened by three independent reviewers. Initial screening of databases yielded 341 publications, of these, three fulfilled all the criteria for inclusion. All three studies showed thinning of the retinal nerve fibre layer, whereas there were no significant changes in the ganglion cell layer. This systematic review demonstrated that thinning of the retinal nerve fibre layer (but not of the ganglion cell layer) is associated with mTBI. It provides preliminary evidence for the use of the retinal nerve fibre layer as a potential biomarker of damage to the visual system in mTBI. Further prospective longitudinal studies ensuring uniform diagnosis and accurate phenotyping of mTBI are needed to understand the effects on the visual system and potential of OCT as a prognostic biomarker.
ophthalmology